scholarly journals Streptococcus suis infection: Clinical manifestations

2005 ◽  
Vol 58 (5-6) ◽  
pp. 236-239 ◽  
Author(s):  
Julijana Dragojlovic ◽  
Branko Milosevic ◽  
Neda Sasic ◽  
Miomir Pelemis ◽  
Milan Sasic
Keyword(s):  
Hearing Loss ◽  
Bacterial Meningitis ◽  
Clinical Symptoms ◽  
Clinical Manifestations ◽  
Sensorineural Deafness ◽  
Streptococcus Suis ◽  
The Body ◽  
Effective Prevention ◽  
Sporadic Disease ◽  
Male Patients

Introduction Streptococcus suis is a bacterium causing a disease in pigs and rarely in humans. This zoonosis is mostly found as a sporadic disease in individuals that were in contact with the affected or infected pigs: farmers, veterinarians and workers engaged in fresh pork processing. It is assumed that the bacterium enters the body through a cut abrasion in the skin. Initially, the condition resembles a flu, followed by signs of bacteriemia and sepsis. The most frequent clinical manifestation of Streptococcus suis infection is meningitis, leading to hearing loss in over 75% of patients, and subsequent arthritis, endophtalmitis, endocarditis and pneumonia. Toxic shock syndrome with hemorhagic manifestations rarely develops. Material and methods This study included five male patients aged 22 to 63 years treated in the Intensive Care Unit of the Institute of Infectious and Tropical Diseases in Belgrade, due to Streptococcus suis infection. The aim of this study was to point to the existence of this bacteria in our environment, to describe clinical manifestations of the disease and to point out the importance of its prevention. Results All patients had epidemiological evidence of being in contact with pork meat. There were no data about diseased pigs. The estimated incubation period was 4 to 8 days. All patients had meningeal signs. Clinical symptoms included shivering, fever, vomiting, headache, malaise, vertigo and tinitus. Three patients presented with alerterd level of awareness. Four patients developed very severe bilateral hearing impairemnt, whereas one endophtalmtis and one developed endocarditis. The cerebrospinal fluid (CSF) was opalescent in four patients, and only one patient presented with clear CSF. CSF examination showed typical changes characeteristic for bacterial meningitis. Streptoccocus suis was isolated in CSF in all patients, and in one patient the bacteria was isolated in blood as well. All patients underwent treatment with II and III generation cephalosporins and one with one aminoglycosides. All patients were cured, but 4 of them developed sequelae like permanent sensorineural deafness and mild ataxia. Conclusions Streptococcus suis infection is present as a zoonosis in pigs, while humans are contracted occasionally, most frequently related to occupational risk. In cases with bacterial meningitis with sepsis and hearing loss, Streptococcus suis infections must be suspected. Effective prevention requires collaboration between epidemiologists, veterinarians and human medicine physicians. .

Sensorineural hearing loss after bacterial meningitis in children residing in Nur-Sultan

2020 ◽  
Vol 18 (4) ◽  
pp. 189-194
Author(s):  
A. Seidullayeva ◽  
◽  
D. Bayesheva ◽  
B. Turdalina ◽  
A. Altynbekova ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Bacterial Meningitis ◽  
Sensorineural Hearing Loss ◽  
Hearing Aids ◽  
Cochlear Implantation ◽  
Clinical Manifestations ◽  
Otoacoustic Emission ◽  
Neurological Complications ◽  
Viral Meningitis ◽  
Sensorineural Hearing

Bacterial meningitis (BM) is a widespread health problem characterized by severe clinical manifestations and high incidence of neurological complications. BM remains one of the main causes of disability and mortality among young children all over the world. Hearing loss is one of neurological complications associated with BM. It accounts for up to 60%–90% of all cases of acquired sensorineural hearing loss (SNHL). Between 2015 and 2018, we performed screening for SNHL among children who had had BM. Seven out of 62 patients examined (11.3%) were found to have SNHL. BM was primarily caused by Streptococcus pneumoniae (n = 4) and Neisseria meningitidis (n = 3). Three out of 4 patients had grade 3–4 SNHL. Computed tomography revealed cochlear ossification in two children and cochlear fibrosis in one child (who had successful cochlear implantation later). For the rest of the patients, we recommended hearing aids. We also found that hearing loss usually develops after BM and does not affect patients with viral meningitis (caused by enteroviruses). We recommend that children with BM undergo regular screening for SNHL (every 3 days during treatment) using otoacoustic emission. These patients should be also examined by an audiologist after discharge from hospital and then every three months for a year. Key words: children, cochlear implantation, meningitis, sensorineural hearing loss, acquired deafness

Hearing disorders in cats: Classification, pathology and diagnosis

2017 ◽  
Vol 19 (3) ◽  
pp. 276-287 ◽  
Author(s):  
George M Strain
Keyword(s):  
Hearing Loss ◽  
Hair Cells ◽  
Genetic Disorder ◽  
Companion Animals ◽  
Sensorineural Deafness ◽  
The Body ◽  
Clinical Aspects ◽  
Cochlear Hair Cells ◽  
Unilateral Deafness ◽  
Auditory Evoked Response

Practical relevance: Auditory function is a sense that is central to life for cats - being important in situational awareness of potential predators, pursuit of prey, and for communication with conspecifics, humans and other species. Deafness in cats is most frequently the result of a genetic disorder, strongly associated with white fur and blue eyes, but may also result from acquired causes such as advancing age, ototoxic drugs, infection, environmental noise and physical trauma. Deafness can be sensorineural, where there is loss of cochlear hair cells, or conductive, where sound is muffled on its way to the inner ear. Clinical challenges: Establishing whether a cat is deaf can be difficult as behavioral testing of hearing is subjective and does not reliably detect unilateral deafness. Brainstem auditory evoked response testing is an objective measure but is limited in its availability. Currently, sensorineural deafness is irreversible because no treatments are available to restore lost hair cells. Conductive hearing loss can usually be treated, although full hearing recovery following otitis media may take weeks as the body clears the middle ear of debris. Evidence base: The author draws on the published literature and his extensive research on clinical aspects and molecular genetics of deafness, principally in companion animals, to review types and forms of deafness in cats. He also discusses current diagnostic approaches and provides brief advice for managing cats with hearing loss.

scholarly journals Clinical manifestations of neurofibromatosis type 1 – a diagnostic and management challenge

2018 ◽  
Vol 128 (3) ◽  
pp. 107-110
Author(s):  
Anna Maria Dąbrowska ◽  
Agnieszka Zwolak
Keyword(s):  
Neurofibromatosis Type 1 ◽  
Clinical Symptoms ◽  
Spontaneous Mutation ◽  
Positive Family History ◽  
Clinical Manifestations ◽  
Neurofibromatosis Type ◽  
The Body ◽  
Coarctation Of Aorta ◽  
Management Challenge

Abstract Introduction. Neurofibromatosis type 1 (NF1), caused by mutation of the tumour-suppressor gene encoding neurofibromin, is an autosomal dominant disorder affecting various organs. Aim. The aim of the study was to discuss the clinical symptoms of NF1 based on seven cases of the disease with regard to the literature. Material and methods. We analyzed retrospectively patients with NF1 (4 females and 3 males) aged 19-52 who were treated at Endocrinology Department between 2003 and 2017. The diagnosis was made in childhood (4 patients) or in adolescence (3 cases), based on clinical symptoms and genetic tests. Results. Five patients had a positive family history of NF1, two cases represented spontaneous mutation. All of analyzed subjects presented café-au-lait spots and neurofibromas on the body. We observed neurological disorders such as: epilepsy (2 patients), Arnold-Chiari malformation (1 man), benign brain neoplasms (2 persons). Optic gliomas appeared in two cases. Tumours were also found in other organs, including the uterus (2 women), the lung, the adrenals, the pituitary and the parathyroid gland (with signs of primary hyperparathyroidism) – each tumour in another patient. Four subjects suffered from cognitive impairment. Skeletal manifestations of neurofibromatosis type 1 such as scoliosis (1 man) and short stature (6 patients) have been noted as well. Five patients presented thyroid disorders – hypothyroidism due to Hashimoto’s disease (4 patients), toxic nodular goiter (1 woman). Other clinical symptoms e.g. vitiligo, alopecia areata and coarctation of aorta have also been found. Conclusions. Variety of clinical symptoms causes that NF1 still remains a diagnostic and management challenge for many physicians. Therefore, multidisciplinary approach is needed to optimize patients’ treatment.

scholarly journals Enterosorbent for endotoxicosis as a factor influencing the development of young cattle

2019 ◽  
Vol 190 (11) ◽  
pp. 66-70
Author(s):  
А. КРАСНОПЕРОВ ◽  
A. KRASNOPEROV ◽  
С. Малков ◽  
S. Malkov ◽  
Наталья Верещак ◽  
...  
Keyword(s):  
Clinical Symptoms ◽  
Recovery Period ◽  
Clinical Manifestations ◽  
The Body ◽  
Control Group ◽  
Phagocytic Cells ◽  
Immunological Parameters ◽  
Endogenous Intoxication ◽  
Newborn Calves ◽  
Young Cattle

Abstract. Purpose – study the effect of enterosorbent on the immunological parameters of blood and the productivity of young cattle. Methods. The object of the study was newborn calves from 2 to 6 days of age (n = 54). Studies on the enterosorbent based on colloidal silicon dioxide (CSD) for calves with alimentary dyspepsia have been carried out. During the experiment, the clinical condition of the animals, the increase in live body weight were evaluated, blood samples were taken for immunohematological studies. Results. In calves at 2–6 days of age, alimentary dyspepsia is accompanied by the development of endogenous intoxication of the body. Animals show leukocytosis – 16.60 ± 5.11×109/l; leukocyte shift to the left with an increase in the number of adolescent and stab neutrophils – 1.41 ± 0.23×109/l; monocytes up to 1.21 ± 0.13x×109/l; circulating immune complexes (CIC) level in blood serum up to 202.4 ± 8.5 cu Under conditions of endogenous intoxication, the immunological protection of the organism was characterized by an increase in the number of phagocytic cells to 71 % of the total number of granulocytes. Clinical symptoms of endogenous intoxication in 86 % of cases disappeared by the 5th day of the use of enterosorbent CSD in the treatment regimen of calves with alimentary dyspepsia. This is associated with blocking and weakening the inflammatory response in the gastrointestinal tract. The effect of enterosorbent CSD on the immunological parameters was expressed in a balanced stabilization of the processes of phagocytosis and immunogenesis. The trend towards normalization of immunological parameters was registered: the level of the CIC was significantly reduced to 97.5 ± 5.48 cu; the phagocytic activity (PA) of the neutrophilic cells was 50.1 ± 2.4 %. Treatment of animals according to the basic scheme approved by the farm turned out to be less effective. In calves that did not receive enterosorbent CSD, in 11 % of cases, clinical manifestations of endogenous intoxication were recorded up to and including 14 days. In these animals, the level of the CIC remained high – 143.6 ± 8.57 cu, the voltage of phagocytic function was noted – 64.3 ± 7.6 % and the imbalance in the ratio of T/B-lymphocytes – 1.13 (normal 1.5–2.0). The effect of the CSD enterosorbent on the calves productivity was reflected in the fact that the rate of weight gain during the experiment was higher in the experimental group. At 4 months, their weight was 149.17 ± 13.57 kg, while in the control group and the comparison group – 135.00 ± 5.00 and 130.00 ± 22.73 kg, respectively. Scientific novelty. Alimentary dyspepsia causes the development of endogenous intoxication in the body of newborn calves. The lack of therapeutic measures leads to a long recovery period and a decrease in productivity.

scholarly journals PATOMEKANISME PENYAKIT GAGAL JANTUNG KONGESTIF

el–Hayah ◽  
2014 ◽  
Vol 4 (2) ◽  
pp. 81 ◽  
Author(s):  
Lailia Nur Rachma
Keyword(s):  
Heart Failure ◽  
Clinical Manifestations ◽  
The United States ◽  
Clinical Syndrome ◽  
The Body ◽  
Reduced Ejection Fraction ◽  
Patients With Heart Failure ◽  
Male Patients ◽  
Failure Prognosis ◽  
The Cost

<em>Heart failure is a clinical syndrome characterized by abnormalities in the structure or function of the heart, resulting in inability of heart to pump blood to meet the metabolic needs of the body tissue. Heart failure is characterized by clinical manifestations such as circulation congestion, tightness, fatigue, and weakness. Heart failure is a major problem in industrial and developing Country. Currently, the incidence and prevalence of heart failure tends to increase, it is also accompanied by an increase in mortality of heart failure cases. In the United States, 1 million patients hospitalized due to heart failure cases, which contribute to 50,000 deaths each year. While the number of visits to the hospital due to heart failure estimated at 6.5 million. Heart failure prognosis is generally poor despite the patients accepted adequate therapy. From the data obtained, only about 35% of male patients and 50% female patients who survived after the onset of acute heart failure. Generaly, the data obtained high mortality are occurs in patients with grade IV (presence of symptoms at rest) is about 30-70%, grade III (presence of symptoms with mild activity) 10-20%, class II (presence of symptoms when the activity being 5-10 %). Higher mortality was found in older patients, men, patients with reduced ejection fraction, and in patients with coronary disease. Once someone is suffering from heart failure, then he shall bear the very high cost. In America, the cost of issued for heart failure therapy between 15-40 trillion US$. In this review, we will discuss about pathomechanism of heart failure. So it is expected to be a reference to the diagnosis of patients with heart failure, which is expected to be recognized early on that could ultimately improve the quality of heart failure patient life, and reduce the number of mortality due to heart failure</em>

Immunological mechanisms of occupational hearing loss in workers of oil-producing and petrochemical industries

2021 ◽  
pp. 73-80
Author(s):  
Alfiya Dinislamovna Volgareva ◽  
Elmira Radikovna Shaikhlislamova ◽  
Lyaylya Marselyevna Masyagutova ◽  
Liliya Kazimovna Karimova ◽  
Galina Ganinovna Gimranova ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Immune System ◽  
Clinical Manifestations ◽  
The Body ◽  
Auditory Analyzer ◽  
Working Posture ◽  
Immunological Mechanisms ◽  
Long Term Impact ◽  
Petrochemical Industries ◽  
Occupational Hearing Loss

Most jobs in the oil and petrochemical industries are characterized by exposure to industrial noise, air pollution of the working area with harmful chemicals, dynamic and static loads, forced working posture, and nervous and emotional overstrain. The complex, long-term impact of these factors on workers leads to the development of fatigue, disruption of the adaptive mechanisms of the body and the formation of pathology of the hearing organ. These changes are most pronounced at the initial stages of the formation of professional hearing loss. In order to study the role of immune mechanisms in the pathogenesis of occupational hearing loss, major groups of immunoglobulins (A, M, G, E) in blood serum were determined. The identification of mature T-cell populations was carried out by indirect immunofluorescence method with monoclonal antibodies of the ICO series (CD3+, CD4+, CD8+, CD16+, CD20+) in 120 workers. The state of the immune status of employees of the main professions can be characterized by the presence of a tendency to form a secondary immunodeficiency state, manifested by the suppression of both cellular and humoral links. Violations of individual parts of the immune system among employees of «noise» industries reflect the level of adaptive reactions of the body and correlate with changes in the auditory analyzer and can develop long before the clinical manifestations of the disease. Identification of subclinical changes in the indicators of the immune system of the body of employees will allow timely preventive and pathogenetically justified rehabilitation measures, prevent the progression of the process and its transformation into professional hearing loss and preserve their ability to work for a long period.

scholarly journals Weil’s syndrome (Leptospiral infection): A case report

2007 ◽  
Vol 60 (9-10) ◽  
pp. 493-496
Author(s):  
Zeljko Mijailovic ◽  
Predrag Canovic ◽  
Olgica Gajovic
Keyword(s):  
Renal Failure ◽  
Case Report ◽  
Clinical Symptoms ◽  
Clinical Manifestations ◽  
Severe Form ◽  
The Body ◽  
Symptomatic Therapy ◽  
Clinical Syndromes ◽  
Febrile Condition ◽  
Therapeutic Measures

Introduction. Leptospirosis is an acute zoonotic infection, caused by spirochetes of the genus Leptospira. It is characterized by extensive vasculitis. It is usually transmitted indirectly, per contaminated water, rarely directly, through contact with infected animals. Leptospira bacteria commonly enter the body through damaged skin or mucous membranes. The clinical syndromes may vary from a subclinical infection and mild febrile condition to severe clinical symptoms with jaundice and renal failure. Case report. This is a case report of a patient with leptospirosis (Weil's disease) whose clinical manifestations included: icterus, renal failure, hemorrhagic syndrome and disturbances of consciousness. After the use of antibiotics, symptomatic and substitution therapy, all symptoms resolved completely. However, in our patient, hemodialysis was necessary due to renal failure, as a palliative measure. Discussion. Weil?s syndrome is a severe form of leptospirosis, which can be fatal. Early clinical diagnosis of the disease, as well as serologic verification of infection, are very important prerequisites, followed by antibiotic and other symptomatic therapy, as soon as possible. Conclusion. This is a case report of a patient with rare clinical manifestations of leptosirosis. Although presenting with severe symptoms, thanks to palliative therapeutic measures, complete and fast recovery was achieved. We especially point out the role of hemodialysis in the treatment of this patient. .

scholarly journals FEATURES OF CLINICAL MANIFESTATIONS OF GONARTHRITIS IN WOMEN WITH HYPERTENSION AND OVERWEIGHT

2021 ◽  
Vol 48 (1) ◽  
Author(s):  
I. M. Fushtey ◽  
A. M. Pidlubna
Keyword(s):  
Informed Consent ◽  
Musculoskeletal System ◽  
Social Problem ◽  
Clinical Symptoms ◽  
Clinical Manifestations ◽  
Pain Syndrome ◽  
The Body ◽  
City Hospital ◽  
The City ◽  
Passive Movements

Abstract One of the diseases that is quite common in modern rheumatology and leads to dysfunction of the musculoskeletal system and creates a major medical and social problem, is gonarthrosis. The incidence of degenerative-dystrophic diseases in HA in women is two to four times higher than in men. In order to establish the patterns of clinical manifestations of GA in women with hypertension (GC) and overweight (HB) of the body, on the basis of the rheumatology department of the city KNP «City Hospital №10» ZMR (Zaporozhye), with informed consent, was prospectively examined 198 women for the period 2018–2020. According to the results of the study, a significant (p <0.05) deterioration of clinical symptoms in women with a combined course of HA with GC and HB, relative to the isolated course of HA, on the indicators: pain during active and passive movements and palpation, stiffness, crepitation and swelling of the joints. The correlations between clinical manifestations of HA, arthrosonographic data and BMI have been established. The characteristics of the pain syndrome associated with exercise, impaired mobility and functionality of the joints significantly increased with increasing stage of GA, joining comorbid pathology and increased BMI.  Keywords: gonarthrosціis, comorbidity, hypertension, overweight.

scholarly journals Toxin-like peptides in plasma, urine and faecal samples from COVID-19 patients

F1000Research ◽  
2021 ◽  
Vol 10 ◽  
pp. 550
Author(s):  
Carlo Brogna ◽  
Simone Cristoni ◽  
Mauro Petrillo ◽  
Maddalena Querci ◽  
Ornella Piazza ◽  
...  
Keyword(s):  
Clinical Symptoms ◽  
Clinical Manifestations ◽  
The Body ◽  
Large Set ◽  
Human Genes ◽  
Peptide Fraction ◽  
Faecal Samples ◽  
Pulmonary Manifestations ◽  
Extra Pulmonary ◽  
Toxic Components

Background: SARS-CoV-2 that causes COVID-19 disease and led to the pandemic currently affecting the world has been broadly investigated. Different studies have been performed to understand the infection mechanism, and the involved human genes, transcripts and proteins. In parallel, numerous clinical extra-pulmonary manifestations co-occurring with COVID-19 disease have been reported and evidence of their severity and persistence is increasing. Whether these manifestations are linked to other disorders co-occurring with SARS-CoV-2 infection, is under discussion. In this work, we report the identification of toxin-like peptides in COVID-19 patients by application of the Liquid Chromatography Surface-Activated Chemical Ionization – Cloud Ion Mobility Mass Spectrometry.   Methods: Plasma, urine and faecal samples from COVID-19 patients and control individuals were analysed to study peptidomic toxins’ profiles. Protein precipitation preparation procedure was used for plasma, to remove high molecular weight proteins and efficiently solubilize the peptide fraction; in the case of faeces and urine, direct peptide solubilization was employed.   Results: Toxin-like peptides, almost identical to toxic components of venoms from animals, like conotoxins, phospholipases, phosphodiesterases, zinc metal proteinases, and bradykinins, were identified in samples from COVID-19 patients, but not in control samples.  Conclusions: The presence of toxin-like peptides could potentially be connected to SARS-CoV-2 infection. Their presence suggests a possible association between COVID-19 disease and the release in the body of (oligo-)peptides almost identical to toxic components of venoms from animals. Their involvement in a large set of heterogeneous extra-pulmonary COVID-19 clinical manifestations, like neurological ones, cannot be excluded. Although the presence of each individual symptom is not selective of the disease, their combination might be related to COVID-19 by the coexistence of the panel of the here detected toxin-like peptides. The presence of these peptides opens new scenarios on the aetiology of the COVID-19 clinical symptoms observed up to now, including neurological manifestations.

scholarly journals Chemical Additives from the Composition of Plastic Products and Other Materials in Establishing Diagnosis for Alergy Disease

2018 ◽  
Vol 55 (4) ◽  
pp. 609-612
Author(s):  
Gheorghe Raftu ◽  
Geta Mitrea ◽  
Luana Andreea Macovei ◽  
Aurel Nechita
Keyword(s):  
Clinical Examination ◽  
Clinical Symptoms ◽  
Clinical Manifestations ◽  
Allergic Diseases ◽  
The Body ◽  
Skin Tests ◽  
Chemical Additives ◽  
Number Of Patients ◽  
Two Stages ◽  
Plastic Products

Many of the chemical additives in the plastic products, besides the possible safety problems that may arise during the production process, have negative effecty, too, on the environment and human health. Plastic is a synthetic polymer. The polymers include starch, latex and cellulose, combined with different substances and chemicals, used in various formulas, the polymer is included in the naylon. At high temperatures such as microwave oven temperature, polymers can migrate from the packaging plastic in food. In most cases, establishing the diagnosis of allergic disease is a complex and difficult operation. This difficulty is primarily related to the polymorphism of the clinical manifestations accompanying allergic reactions, the existence during the evolution of these conditions, of long clinical asymptomatic latencies, as well as due to numerous subjective and objective symptoms that overlap with those caused by the allergen, complicating and altering the clinical picture. Allergies are an abnormal reaction of the body to allergens and develop in two stages. After the first contact with the allergen, the IgE antibodies are produced, and the second contact produces the allergic reaction. The produced antibodies will release the chemical mediators (histamine, prostaglandine, etc.) which cause an inflammatory response, vascular changes and irritation of the tissues, with the appearance of symptoms specific to allergy: redness, rash, itching, edema, etc.The so complex symptom of allergic diseases comprises several systems and organs at the same time, and the existence of over-additive phenomena makes it impossible to have characteristic clinical symptoms of allergic diseases that allow their identification only by clinical examination. However, this does not mean that the clinical exam and the analysis of the various objective and subjective symptoms presented by the patient is of no importance in establishing the diagnosis and recognizing the allergic character of the disease.The study includes a number of patients studied at the Galati Allergy Clinic. Specific immunotherapy known as desensitization or anti-allergic vaccination, is designed to fight the causes of allergies that occur when the immune system misinterprets harmless substances. Clinical examination results are complemented by allergen and specific antibody research; skin tests are the most common method for allergen detection.

Sign in / Sign up

Export Citation Format

Share Document